Northern Trust Corp Raises Position in Maximus, Inc. (NYSE:MMS)

Northern Trust Corp grew its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 13.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 815,133 shares of the health services provider's stock after purchasing an additional 94,858 shares during the quarter. Northern Trust Corp owned about 1.43% of Maximus worth $60,850,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in MMS. Aquatic Capital Management LLC grew its position in shares of Maximus by 128.8% during the 4th quarter. Aquatic Capital Management LLC now owns 15,328 shares of the health services provider's stock worth $1,144,000 after buying an additional 8,628 shares during the period. Oxford Asset Management LLP acquired a new position in shares of Maximus during the fourth quarter worth approximately $978,000. New Vernon Capital Holdings II LLC bought a new position in shares of Maximus in the fourth quarter valued at $214,000. Nebula Research & Development LLC increased its position in shares of Maximus by 3.2% during the fourth quarter. Nebula Research & Development LLC now owns 17,004 shares of the health services provider's stock worth $1,269,000 after acquiring an additional 534 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its holdings in shares of Maximus by 7.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock worth $92,188,000 after acquiring an additional 84,835 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Stock Performance

Shares of MMS traded down $0.43 during mid-day trading on Friday, hitting $75.31. The stock had a trading volume of 598,966 shares, compared to its average volume of 561,986. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The firm has a market cap of $4.26 billion, a P/E ratio of 16.20 and a beta of 0.61. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The business has a fifty day moving average price of $68.07 and a 200-day moving average price of $73.15.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.57 earnings per share. On average, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.59%. Maximus's payout ratio is 25.81%.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Maximus from a "hold" rating to a "buy" rating in a report on Wednesday.

Insider Buying and Selling

In other news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.